Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals

Metabolism: Clinical and Experimental

Volumn 64, Issue 6, 2015, Pages 729-737

  Joy, Nino G ^a   Tate, Donna B ^a   Davis, Stephen N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Glucagon; Glyburide; Hypoglycemia; Neuroendocrine counterregulation

Indexed keywords

ADRENALIN; C PEPTIDE; GLIBENCLAMIDE; GLIMEPIRIDE; GLUCAGON; GLUCOSE; INSULIN; LEPTIN; NORADRENALIN; PLACEBO; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; PANCREAS POLYPEPTIDE; SULFONYLUREA DERIVATIVE;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HORMONE RESPONSE; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; METABOLIC REGULATION; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE; BLOOD; METABOLISM;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; LEPTIN; MALE; PANCREATIC POLYPEPTIDE; SINGLE-BLIND METHOD; SULFONYLUREA COMPOUNDS;

EID: 84927958927     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.02.006     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention National diabetes fact sheet www.cdc.gov/diabetes/pubs/pdf/ndfs-2011 2011
2. A.S. Gangji, T. Cukierman, H.C. Gerstein, C.H. Goldsmith, and C.M. Clase A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin Diabetes Care 30 2 2007 389 394
3. A.D. Harrower Comparative tolerability of sulphonylureas in diabetes mellitus Drug Saf 22 4 2000 313 320
4. A. Holstein, A. Plaschke, and E.H. Egberts Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide Diabetes Metab Res Rev 17 2001 467 473
5. S. Seino ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies Annu Rev Physiol 61 1999 337 362
6. E. Szoke, N.R. Gosmanov, J.C. Sinkin, A. Nihalani, A.B. Fender, and P.E. Cryer Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia Metabolism 55 1 2006 78 83
7. E.W. ter Braak, A.M. Appelman, I. van der Tweel, D.W. Erkelens, and T.W. van Haeften The sulfonylurea glyburide induces impairment of glucagon and growth hormone responses during mild insulin-induced hypoglycemia Diabetes Care 25 2002 107 112
8. N.N. Abumrad, D. Rabin, M.P. Diamond, and W.W. Lacy Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man Metabolism 30 9 1981 936 940
9. R. DeFronzo, K. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E216 E223
10. S.A. Amiel, W.V. Tambolane, D.C. Simonson, and R. Sherwin Defective glucose counterregulation after strict control of insulin-dependent diabetes mellitus N Engl J Med 316 1987 1376 1383
11. S.N. Davis, C. Shavers, and F. Costa Differential gender responses to hypoglycemia are due to alterations in CNS drive and not glycemic thresholds Am J Physiol 279 2000 E1054 E1063
12. D.L. Hachey, W.R. Parsons, S. McKay, and M.W. Haymond Quantitation of monosaccharide isotopic enrichment in physiologic fluids by electron ionization or negative chemical ionization GC/MS using di-O-isopropylidene derivatives Anal Chem 71 20 1999 4734 4739
13. R. Steele, J.S. Wall, R.C. De Bodo, and N. Altszuler Measurement of size and turnover rate of body glucose pool by the isotope dilution method Am J Physiol 187 1956 15 24
14. E. Aguilar-Parada, A.M. Eisentraut, and R.H. Unger Pancreatic glucagon secretion in normal and diabetic subjects Am J Med Sci 257 1969 415 419
15. L. Wide, and J. Porath Radioimmunoassay of proteins with the uses of sephadex-coupled antibodies Biochim Biophys Acta 130 1966 257 260
16. R. Causon, M. Caruthers, and R. Rodnight Assay of plasma catecholamines by liquid chromatography with electrochemical detection Anal Biochem 116 1982 223 226
17. W. Hunter, and F. Greenwood Preparation of [131I]-labeled human growth hormone of high specific activity Nature 194 1962 495 496
18. W. Hagopian, E. Lever, D. Cen, D. Emmonoud, K. Polonsky, and W. Pugh Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog Am J Physiol 245 1983 171 177
19. L. Deary, D. Hepburn, K. Macleod, and B.M. Frier Partitioning the symptoms of hypoglycemia using multi-sample confirmatory factor analysis Diabetologia 36 1993 771 777
20. R. Weitgasser, M. Lechleitner, A. Luger, and A. Klingler Effects of glimepiride on HbA1c and body weight in type 2 diabetes: results of a 1.5 year follow-up study Diabetes Res Clin Pract 61 2003 13 19
21. DiaBeta [package insert] 2013 Sanofi-Aventis Bridgewater, NJ
22. Amaryl [package insert] 2013 Sanofi-Aventis Bridgewater, NJ
23. L. Landstedt-Hallin, U. Adamson, and P.E. Lins Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes J Clin Endocrinol Metab 84 1999 3140 3145
24. S. Banarer, V.P. McGregor, and P.E. Cryer Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response Diabetes 51 4 2002 958 965
25. M.L. Evans, R.J. McCrimmon, D.E. Flanagan, T. Keshavarz, X. Fan, and E.C. McNay Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses Diabetes 53 10 2004 2542 2551
26. Y. Wang, H. Zheng, and S. Liu Effects of ATP-sensitive potassium channels on the expression of P21, P27 and leptin J Huazhong Univ Sci Technolog Med Sci 29 1 2009 8 11 10.1007/s11596-009-0102-8
27. H. Sakura, C. Ammälä, P.A. Smith, F.M. Gribble, and F.M. Ashcroft Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle FEBS Lett 377 3 1995 338 344
28. N. Inagaki, Y. Tsuura, N. Namba, K. Masuda, T. Gonoi, and M. Horie Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart Biol Chem 270 11 1995 5691 5694
29. L. Aguilar-Bryan, C.G. Nichols, S.W. Wechsler, J.P. Clement IV, A.E. Boyd III, and G. González Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion Science 268 5209 1995 423 426
30. N. Inagaki, T. Gonoi, J.P. Clement, C.Z. Wang, L. Aguilar-Bryan, and J. Bryan A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K + channels Neuron 16 5 1996 1011 1017
31. A. Melander Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes: brief overview Diabetes 53 Suppl 3 2004 S151 S155
32. G. Müller, D. Hartz, J. Pünter, R. Okonomopulos, and W. Kramer Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics Biochem Biophys Acta 1191 2 1994 267 277
33. W. Kramer, G. Müller, F. Girbig, U. Gutjahr, S. Kowalewski, and D. Hartz The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels Diabetes Res Clin Pract 1995 S67 S80 [Suppl]